secwatch.observer — SEC 8-K summary
======================================

Issuer:     VITASPRING BIOMEDICAL CO. LTD. (—)
CIK:        0001697884
Form:       8-K
Filed at:   2023-01-27T23:59:59+00:00
Accession:  0001697884-23-000002
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vitaspring Biomedical dismisses auditor Kho & Patel; engages TAAD LLP; prior report had going concern
--------------------------------------------------------------------------------

- Kho & Patel resigned as auditor on Jan 17, 2023; no disagreements or reportable events.
- Kho & Patel's last report for FY ended Jan 31, 2022 and 2021 contained a going concern explanatory paragraph.
- Board approved engagement of TAAD LLP as new independent auditor on Jan 24, 2023.
- No prior consultations with TAAD regarding accounting principles or audit opinions for current or prior periods.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1697884/000169788423000002/0001697884-23-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1697884/000169788423000002/vsbc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001697884-23-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer